Circulating Tumor Cells-driven choice of first line therapy for ER+HER2-metastatic breast cancer: overall survival analysis of the randomized STIC CTC trialFrancois-Clement Bidard, Nicolas Kiavue,Catherine Alix-Panabieres, Sylvain Dureau,Thomas Bachelot,Hugues Bourgeois,Anthony Goncalves,Etienne Brain,Sylvain Ladoire,Florence Dalenc,Joseph Gligorov,Luis Teixeira,George Emile,Jean-Marc Ferrero,Delphine Loirat,Luc Cabel,Veronique Dieras,Frederique Berger,William Jacot,Jean-Yves PiergaCANCER RESEARCH(2023)引用 0|浏览18暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要